4//SEC Filing
Aldeyra Therapeutics, Inc. 4
Accession 0000899243-17-006713
$ALDXCIK 0001341235operating
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 5:45 PM ET
Size
5.5 KB
Accession
0000899243-17-006713
Insider Transaction Report
Form 4
Clark David J
Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-03-03+155,656→ 155,656 totalExercise: $5.10Exp: 2027-03-02→ Common Stock (155,656 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2017.
Documents
Issuer
Aldeyra Therapeutics, Inc.
CIK 0001341235
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001341235
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 5:45 PM ET
- Size
- 5.5 KB